Member Exclusive News

The week in industry: Recardio to halt UK heart trial due to Brexit uncertainty

Read our round-up of some of the breaking news from the pharmaceutical industry over the past week. This week: Lilly acquires rights to Chugai's experimental diabetes drug and the USA and Cuba announce first joint biotech venture.

Thumb untitled design
Oct 04, 2018

Please sign in or register for FREE

No comments yet.